2016 Hematological Malignancies

First page Previous page 182 Next page Last page

GHSG Risk Allocation for HL Patients

Stage (Ann Arbor)

Risk factors

IA, IB, IIA

IIB

IIIA, IIIB

IVA, IVB

Early favorable

None

≥3 LN areas

Advanced

Elevated ESR

Early unfavorable

Large med mass

Extranodal disease

Made with